NCT00496275已完成1 期
A Phase I, Open Label Study to Assess the Safety and Tolerability of ZD6474 (ZACTIMA) in Combination With Vinorelbine (Navelbine) or Gemcitabine (Gemzar) Plus Cisplatin as First Line Therapy in Patients With Locally Advanced or Metastatic (Stage IIIB-IV) Non Small Cell Lung Cancer.
Genzyme, a Sanofi Company0 个研究点目标入组 17 人开始时间: 2006年8月1日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 17
- 主要终点
- Establish safety and tolerability of ZACTIMA in combination with vinorelbine plus cisplatin or gemcitabine plus cisplatin
研究概览
简要总结
To test the safety and tolerability of ZD6474 in combination withVinorelbine (Navelbine) or Gemcitabine (Gemzar) plus cisplatin as first line therapy in patients with locally advanced or metastatic (Stage IIIB-IV) Non Small Cell Lung Cancer.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmed non small cell lung cancer (stage IIIB-IV)
- •Life expectancy greater than 12 weeks
- •At least 1 measurable lesion greater than 10mm in smallest diameter.
排除标准
- •Prior treatment with anticancer agent
- •Brain metastases
- •Major surgery within last 4 weeks
结局指标
主要结局
Establish safety and tolerability of ZACTIMA in combination with vinorelbine plus cisplatin or gemcitabine plus cisplatin
次要结局
- Pharmacokinetics of ZACTIMA, vinorelbine or gemcitabine, plus cisplatin when co-administered(Predetermined timepoints after dose administration)
- Preliminary assessment of efficacy of ZACTIMA when co-administered with vinorelbine plus cisplatin or gemcitabine plus cisplatin
研究者
相似试验
已完成
1 期
Phase I Irinotecan, 5-Fluorouracil and Leucovorin CombinationMetastaticColorectalAdenocarcinomaNCT00507091Genzyme, a Sanofi Company24
已完成
1 期
Phase I FOLFOX CombinationAdvanced Colorectal CarcinomaNCT00499850Genzyme, a Sanofi Company18
已完成
1 期
ZD6474, Cetuximab, and Irinotecan in Patients With Metastatic Colorectal CancerColorectal CancerNCT00436072Dana-Farber Cancer Institute46
撤回
1 期
Trial of ZD6474 and Faslodex in Non-Small Cell Lung CancerCarcinoma, Non Small Cell LungNCT01004419University of Wisconsin, Madison
已完成
1 期
Zactima With Temodar During Radiation Treatment for Newly Diagnosed Stage IV Brain TumorsGliosarcomaGlioblastoma MultiformeNCT00441142Patrick Y. Wen, MD119
